Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Abstract miR-122, a liver-specific tumor suppressor microRNA, is frequently down-regulated
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
[引用][C] Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
S Hsu, B Yu, X Wang, Y Lu, CR Schmidt… - … , Biology and Medicine, 2013 - cir.nii.ac.jp
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
S hao Hsu, B Yu, X Wang, Y Lu… - Nanomedicine …, 2013 - scholar.nycu.edu.tw
Abstract miR-122, a liver-specific tumor suppressor microRNA, is frequently down-regulated
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
[HTML][HTML] Cationic Lipid Nanoparticles for Therapeutic Delivery of siRNA and miRNA to Murine Liver Tumor
S Hsu, B Yu, X Wang, Y Lu, CR Schmidt… - … biology, and medicine, 2013 - ncbi.nlm.nih.gov
Abstract miR-122, a liver-specific tumor suppressor microRNA, is frequently downregulated
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
SH Hsu, B Yu, X Wang, Y Lu… - Nanomedicine …, 2013 - pubmed.ncbi.nlm.nih.gov
miR-122, a liver-specific tumor suppressor microRNA, is frequently down-regulated in
hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
[HTML][HTML] Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.
SH Hsu, B Yu, X Wang, Y Lu, CR Schmidt… - Nanomedicine …, 2013 - europepmc.org
Abstract miR-122, a liver-specific tumor suppressor microRNA, is frequently downregulated
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
S Hsu, B Yu, X Wang, Y Lu, CR Schmidt, RJ Lee… - … , Biology, and Medicine, 2013 - infona.pl
miR-122, a liver-specific tumor suppressor microRNA, is frequently down-regulated in
hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
S hao Hsu, B Yu, X Wang, Y Lu… - Nanomedicine …, 2013 - ohiostate.elsevierpure.com
Abstract miR-122, a liver-specific tumor suppressor microRNA, is frequently down-regulated
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.
SH Hsu, B Yu, X Wang, Y Lu, CR Schmidt… - Nanomedicine …, 2013 - europepmc.org
Abstract miR-122, a liver-specific tumor suppressor microRNA, is frequently downregulated
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …
in hepatocellular carcinoma (HCC). LNP-DP1, a cationic lipid nanoparticle formulation, was …